NicOx Receives Second Payment Under Pfizer Agreement

NicOx S.A. announced it has received a payment of EUR 1 million from Pfizer Inc. in connection with the companies' Research, Option, Development and Licensing agreement that was signed on Aug. 26, 2004. The agreement granted Pfizer an option to acquire an exclusive worldwide license, covering proprietary NicOx nitric oxide-donating compounds.

Investors.com (http://www.investors.com/breakingnews.asp?journalid=26708263)